REVIVA PHARMACEUTICALS HOLDINGS, INC.

Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.

RVPH | US

Overview

Corporate Details

ISIN(s):: VGG8708A1167 (+1 more)
LEI:
Country:: United States of America
Address:: 10080 N WOLFE ROAD, 95014 CUPERTINO
Website:: https://revivapharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for diseases with significant unmet medical needs. The company utilizes a chemical genomics-driven technology platform to develop treatments with improved safety and efficacy profiles. Its primary areas of focus include central nervous system (CNS), respiratory, and metabolic diseases. The company's lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, and psychosis associated with Alzheimer's and Parkinson's diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REVIVA PHARMACEUTICALS HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REVIVA PHARMACEUTICALS HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REVIVA PHARMACEUTICALS HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DONGSUNG PHARMACEUTICAL CO.,LTD A Korean firm making pharmaceuticals, cosmetics, and popular hair care products for over 60 years.	South Korea	002210
DONGWHA PHARM.CO.,LTD Develops, manufactures, and sells a diverse portfolio of healthcare products globally.	South Korea	000020
Dottikon ES Holding AG Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.	Switzerland	DESN
Double Bond Pharmaceutical International AB Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.	Sweden	DBP B
DR REDDYS LABORATORIES LTD Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.	United States of America	RDY
DuChemBio Co, LTD Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.	South Korea	176750
Dx & Vx Co., Ltd. Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.	South Korea	180400
DYNAVAX TECHNOLOGIES CORP Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.	United States of America	DVAX
Dyne Therapeutics, Inc. Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.	United States of America	DYN
Eagle Veterinary Technology Co.,Ltd Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.	South Korea	044960